Source: Cancer Science. Unidade: FM
Subjects: FATORES DE CRESCIMENTO, NEOPLASIAS, VACINAÇÃO, ENDOTÉLIO VASCULAR, ANTINEOPLÁSICOS
ABNT
SANCHES, Jéssica de Souza et al. Anti-bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor-binding response, impairing tumor outgrowth. Cancer Science, v. 107, n. 4, p. 551-555, 2016Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/cas.12903/epdf. Acesso em: 26 ago. 2024.APA
Sanches, J. de S., Aguiar, R. B. de, Parise, C. B., Suzuki, J. M., Chammas, R., & Moraes, J. Z. de. (2016). Anti-bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor-binding response, impairing tumor outgrowth. Cancer Science, 107( 4), 551-555. doi:10.1111/cas.12903NLM
Sanches J de S, Aguiar RB de, Parise CB, Suzuki JM, Chammas R, Moraes JZ de. Anti-bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor-binding response, impairing tumor outgrowth [Internet]. Cancer Science. 2016 ; 107( 4): 551-555.[citado 2024 ago. 26 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/cas.12903/epdfVancouver
Sanches J de S, Aguiar RB de, Parise CB, Suzuki JM, Chammas R, Moraes JZ de. Anti-bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor-binding response, impairing tumor outgrowth [Internet]. Cancer Science. 2016 ; 107( 4): 551-555.[citado 2024 ago. 26 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/cas.12903/epdf